|
 |
Cynthia N. Cornelissen , Ph.D.
Professor
Phone: (804) 827-1754
Dept. Fax: (804) 828-9946
e-mail: cncornel@vcu.edu
Address:
Department of Microbiology & Immunology
Virginia Commonwealth University
PO Box 980678
1101 East Marshall Street, Sanger Hall 6-052
Richmond, VA 23298-0678
Lab
Web Page
Professional Experience
- B.S.,
1984, University of Illinois, Urbana-Champaign
- M.S.,
1986, University of Illinois, Urbana-Champaign
- Ph.D.,
1989, University of Illinois, Urbana-Champaign
-
Postdoctoral, 1989-1991, University of North Carolina at Chapel Hill
- Research
Associate, 1991-1994, University of North Carolina at Chapel Hill
- Research
Assistant Professor, 1994-1997, University of North Carolina at Chapel
Hill
Research Interests:
Neisseria gonorrhoeae
is a human pathogen of significant public health concern
since it causes not only a localized infection but also potentially serious
sequelae including pelvic inflammatory disease and ectopic pregnancy in
women. Recently it has been recognized that bacterial STDs such as gonorrhea
and chlamydial infection are co-factors for HIV transmission, which has
hastened the search for vaccine strategies against bacterial pathogens.
Potential gonococcal vaccine candidates include surface-exposed receptors
necessary for nutrient uptake in vivo. One such candidate is the transferrin
receptor. The components of this receptor are not subject to high-frequency
variation, are expressed by all gonococci, and are required to initiate the
signs and symptoms of urethritis in human male volunteers. In my laboratory,
we are interested in the structure, function and regulation of the
gonococcal transferrin receptor since understanding how the receptor works
is essential if we are to prevent its function in vivo. We are also
evaluating the immunogenicity of these proteins and the functional relevance
of an immune response generated against them.
The gonococcal transferrin receptor is made up of two
proteins: transferrin-binding proteins A and B (TbpA and TbpB). Both of
these proteins bind transferrin and contribute to transferrin-iron uptake.
In its requirement for two different proteins, the gonococcal transferrin
receptor is to be contrasted to other bacterial iron transporters, which
require a single protein. One of the transferrin-binding proteins (TbpA)
shares homology with a family of integral outer membrane proteins that
depend upon energization by a set of proteins including TonB, ExbB and ExbD.
The other transferrin-binding protein (TbpB) is acetylated, substantially
surface-exposed, and antigenically more variable. TbpB preferentially binds
iron-loaded transferrin; thus this protein is postulated to play roles in
recognition of holo-transferrin and in release of deferrated transferrin. We
are interested in the topologies of TbpA and TbpB in the outer membrane,
what domains are critical for transferrin binding and what domains are
surface exposed. This aspect of our studies has obvious vaccine implications
since surface-exposed domains of a receptor are potential targets for
immunoprophylaxis. We are interested in the stoichiometry of the transferrin-binding
proteins in the functional receptor and what effect ligand and TonB-derived
energy have on the resulting stoichiometric relationships.
We have proposed a hypothetical, two-dimensional topology
model of TbpA, based on its homology with other TonB-dependent, outer
membrane transporters, several of which have now been crystallized. Using
this hypothetical model, we designed deletion and insertion strategies, with
which we demonstrated the surface accessibility and functional importance of
several putative loops of TbpA. We determined that transferrin release from
TbpA requires TonB-derived energy. We have also demonstrated that TbpA
physically interacts with TonB forming a stable complex, the formation of
which does not require the presence of chemical cross-linkers. We would like
to further characterize the TonB-TbpA interaction, identifying domains of
both TbpA and TonB required for association and function. Using similar
approaches, we have probed structure-function relationships in TbpB, by
which we identified an amino-terminal transferrin-binding domain which is
required for the wild-type function of TbpB.
Expression of TbpA and TbpB is increased under low-iron
growth conditions, a phenomenon that is mediated by the Fur protein, a
transcriptional repressor of iron-regulated genes that has been well
characterized in other systems. A consensus Fur-binding site precedes the
genes encoding TbpA and TbpB, mutagenesis of which results in constitutive
expression. We have demonstrated that TbpA and TbpB are co-transcribed from
a single transcript, and furthermore that there are segmental differences in
steady-state transcript levels, resulting in a 2:1 ratio of tbpB :
tbpA transcripts. We are currently evaluating the physiological
relevance of an inverted repeat located between tbpA and tbpB
using RT-PCR and fusion technologies. In other systems, the
stoichiometry of multi-subunit complexes is achieved in part by regulation
of expression by intervening stem-loop structures in mRNA transcripts. Thus,
we hypothesize that a similar regulatory mechanism could influence the
stoichiometry of the proteins that comprise the gonococcal transferrin
receptor.
Because TbpA and TbpB are considered viable vaccine
candidates, we evaluated the immune response generated against these
proteins during natural infections in men and women. We determined that
there was only a modest level of Tbp-specific antibodies in the sera from
gonorrhea patients, and Tbp-specific antibodies in mucosal secretions were
below the limits of detection. This suggests that natural infection does not
elicit a vigorous immune response. Thus, we are attempting to construct
immunogenic vaccines, to be delivered intranasally, that will elicit a
protective immune response, even if natural infections do not. To date, we
have been able to generate antigenic, intranasal vaccines comprised of TbpA,
TbpB and the non-toxic B subunit of cholera toxin. These antigens elicited
antibodies that were capable of bactericidal activity against heterologous
gonococci in the presence of human complement. We plan to test the efficacy
of these vaccine antigens in an animal model of gonococcal colonization.
Selected Publications:
Cornelissen C.N., and P.F. Sparling. Iron piracy:
acquisition of transferrin-bound iron by bacterial pathogens. Mol.
Microbiol. 14:843-850 (1994).
Cornelissen C.N., and P.F. Sparling. Binding and
surface-characteristics of the gonococcal transferrin receptor are dependent
on both transferrin-binding proteins. J. Bacteriol. 178:1437-1444 (1996).
Cornelissen C.N., J.E. Anderson, and P.F. Sparling.
Characterization of the diversity and transferrin-binding domain of
gonococcal Tbp2. Infect. Immun. 65:822-828 (1997).
Cornelissen C.N., Anderson JE, Sparling PF.
Energy-dependent changes in the gonococcal transferrin receptor. Mol
Microbiol. 1997 Oct;26(1):25-35.
Cornelissen C.N., Kelley M, Hobbs MM, Anderson JE, Cannon
JG, Cohen MS, Sparling PF. The transferrin receptor expressed by gonococcal
strain FA1090 is required for the experimental infection of human male
volunteers. Mol Microbiol. 1998 Feb;27(3):611-6.
Cornelissen C.N., J.E. Anderson, I.C. Boulton, and P.F.
Sparling: Antigenic and sequence diversity in gonococcal transferrin-binding
protein A (TbpA), Infec. Immun. 68 : 4725-4735, 2000.
Boulton I.C., M.K. Yost, J.E. Anderson, and C.N.
Cornelissen: Idenfication of discrete domains within gonococcal transferrin-binding
protein A (TbpA) that are necessary for ligand binding and iron uptake
functions, Infect. Immun. 68 : 6988-6996, 2000.
Ronpirin C., A. Jerse, and C.N. Cornelissen: The
gonococcal genes encoding transferrin-binding proteins (Tbp) A and B are
arranged in a bicistronic operon but are subject to diffential expression,
Infect. Immun. 69 : 6336-6347, 2001.
Jerse A.E., E.T. Crow, A.N. Bordner, I. Rahman, C.N.
Cornelissen, T. Moench, and K. Mehrazar: Growth of Neisseria gonorhoeae
in female mouse genital tract does not require the gonococcal
transferrin or hemoglobin receptors and may be enhanced by commensal
lactobacilli, Infect. Immuno. 70 : 2549-2558, 2002.
Masri H.P., and C.N. Cornelissen: Specific ligand binding
attributable to individual epitopes of gonococcal transferrin-binding
protein A (TbpA), Infect. Immun. 70 : 732-740, 2002.
Kenney C., and C.N. Cornelissen: Demostration and
characterization of a specific interaction between gonococcal transferrin-binding
protein A and TonB, J. Bacteriol. 184 : 6138-6145, 2002.
Paik, S., A. Brown, C.L. Munro, C.N. Cornelissen, and T.
Kitten: The sloABCR operon of Streptococcus mutans encodes
a Mn and Fe transport system required for endocarditis virulence and its Mn-dependent
repressor, J. Bacteriol. 185 : 5967-5975, 2003.
Price, G.A., M.M. Hobbs, and C.N. Cornelissen:
Immunogenicity of gonococcal transferrin binding proteins during natural
infection, Infect. Immun. 72 : 277-283, 2004.
Yost-Daljev, M.K. and C.N. Cornelissen: Determination of
surface-exposed, functional domains of gonococcal transferrin binding
protein A (TbpA), Infect. Immun., 72 : 1775-1785, 2004.
Price, G.A., M.W.
Russell, and C.N. Cornelissen: Intranasal administration of recombinant
Neisseria gonorrhoeae transferrin binding proteins A and B conjugated
to the cholera toxin B subunit induces systemic and vaginal antibodies in
mice, Infect. Immun., 73 : 3945-3953, 2005.
Hagen, T.A. and C.N.
Cornelissen: Neisseria gonorrhoeae requires expression of TonB and
the putative transporter TdfF to replicate within cervical epithelial cells,
Mol. Microbiol., 62 : 1144-1157, 2006.
DeRocco, A.J. and C.N. Cornelissen: Identification of
transferrin binding domains in TbpB expressed by Neisseria gonorrhoeae,
Infect. Immun. 75(7): 3220-3232, 2007.
Price, G.A., H.P. Masri, A.M. Hollander, M.W. Russell, and
C.N. Cornelissen: Goncoccal transferrin binding protein-cholera toxin B
chimeras induce serum bactericidal and vaginal transferrin-utilization
blocking antibodies in mice, Vaccine, 25(41): 7247-7260, 2007. |